Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Boschi S;Boschi S; Todde S; Todde S
  • Source:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Aug; Vol. 50 (10), pp. 2921-2924.
  • Publication Type:
    Editorial; Comment
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin : Springer-Verlag Berlin, 2002-
    • Subject Terms:
      Radiopharmaceuticals* ; Philosophy*; Humans
    • Comments:
      Comment on: Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):3-6. (PMID: 34655308)
    • References:
      Schweiger M, Wester HJ. How many PET tracers do we need? J Nucl Med. 2011;52(12):36S-41S. (PMID: 10.2967/jnumed.110.085738)
      Arnold C. Theranostics could be big business in precision oncology. Nat Med. 2022;28:606–8. https://doi.org/10.1038/s41591-022-01759-6 . (PMID: 10.1038/s41591-022-01759-635440719)
      Afshar-Oromieh A, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Holland-Letz T, Giesel FL, Kratochwil C, Haufe S, Haberkorn U, Zechmann CM. PET imaging with a [ 68 Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med MolGa] gallium013, 40:486–495. https://doi.org/10.1007/s00259-012-2298-2.
      Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Rörich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, Jäger D, Debus J, Haberkorn U, Giesel FL. 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801–5. https://doi.org/10.2967/jnumed.119.227967 . (PMID: 10.2967/jnumed.119.227967309549396581228)
      Boschi S, Todde S. From radiotracer to radiopharmaceutical: a philosophical approach. Eur J Nucl Med Mol Imaging. 2021. https://doi.org/10.1007/s00259-021-05588-6 . (PMID: 10.1007/s00259-021-05588-634655308)
      Edmonds D, Eidinow J. Wittgenstein's poker: the story of a ten-minute argument between two great philosophers. Faber & Faber; 2002.
      Prasad V, Ioannidis JPA. Constructive and obsessive criticism in science. Eur J Clin Invest. 2022;52: e13839. https://doi.org/10.1111/eci.13839.
      Ligtvoet A, Scholten C, Davé A, King R, Petrosova L, Chiti A, Goulart De Medeiros M, Joerger A. Study on sustainable and resilient supply of medical radioisotopes in the EU. Therapeutic radionuclides. European Commission, JRC Science for policy report 2021. https://doi.org/10.2760/642561.
      Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001on the Community code relating to medicinal products for human use. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:311:0067:0128:en:PDF . Accessed 1 May 2023.
      Heidegger M. Gelassenheit; 1959.
      Rorty R. Philosophy and the mirror of nature. Princeton University Press; 1979.
      Swiss Medtech, Press release 28.11.22, https://www.swiss-medtech.ch/en/news/politicians-decide-favour-patient-care . Accessed 1 May 2023.
    • Accession Number:
      0 (Radiopharmaceuticals)
    • Publication Date:
      Date Created: 20230502 Date Completed: 20230731 Latest Revision: 20230814
    • Publication Date:
      20231215
    • Accession Number:
      10.1007/s00259-023-06244-x
    • Accession Number:
      37130963